Get started
Author

Margot Rubington

Observed name: Rubington, Margot
Observed institutions: Université Paris-Sud, Inserm
OpenAlex ID: A5074354589
Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2016 · Lise Boussemart, Isabelle Girault, et al. · Cancer Research · 61
Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines
2016 · Hélène Malka-Mahieu, Isabelle Girault, et al. · Cell Cycle · 21
PDF
Data from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Table S2 from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Supplementary figure 1 from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Data from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Table S1 from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Supplementary Figures legends from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Supplementary figure 2 from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Table S1 from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Table S2 from Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization
2023 · Lise Boussemart, Isabelle Girault, et al.
Synergistic effects of eIF4A and MEK inhibitors on proliferation of NRAS-mutant melanoma cell lines
2016 · Malka-Mahieu, Hélène, Girault, Isabelle, et al. · Figshare
Works count: 12
Citation count: 82
H-index: 2
I10-index: 2
Year
Topic
Type